Expert Opinion on Biological Therapy, Volume 20, Issue 5 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 20, Issue 5 (2020)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Volume 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Woman in Biologics

Review

Review
Current challenges in biotherapeutic particles manufacturing
Mafalda G. Moleirinho, Ricardo J.S. Silva, Paula M. Alves, Manuel J. T. Carrondo & Cristina Peixoto
Pages: 451-465
Published online: 27 Nov 2019
AbstractforCurrent challenges in biotherapeutic particles manufacturing | Full Text | References | PDF (1.5 MB) | EPUB
  • 18230 Views
  • 59 CrossRef citations
  • 0Altmetric
Open Access
Review
Bioengineering strategies for nephrologists: kidney was not built in a day
Anna Julie Peired, Benedetta Mazzinghi, Letizia De Chiara, Francesco Guzzi, Laura Lasagni, Paola Romagnani & Elena Lazzeri
Pages: 467-480
Published online: 23 Jan 2020
AbstractforBioengineering strategies for nephrologists: kidney was not built in a day | Full Text | References | PDF (1.2 MB) | EPUB
  • 8029 Views
  • 24 CrossRef citations
  • 0Altmetric
Open Access
Review
Immunotherapy for castration-resistant prostate cancer: has its time arrived?
Susan F. Slovin
Pages: 481-487
Published online: 05 Mar 2020
AbstractforImmunotherapy for castration-resistant prostate cancer: has its time arrived? | Full Text | References | PDF (1 MB) | EPUB
  • 393 Views
  • 9 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Will oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide?
Sheila A. Doggrell
Pages: 489-492
Published online: 05 Feb 2020
AbstractforWill oral semaglutide be used to reduce cardiovascular risk in subjects with type 2 diabetes instead of subcutaneous semaglutide? | Full Text | References | PDF (383.3 KB) | EPUB
  • 454 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Biological therapy in hereditary angioedema: transformation of a rare disease
Hilary Longhurst & Henriette Farkas
Pages: 493-501
Published online: 19 Mar 2020
AbstractforBiological therapy in hereditary angioedema: transformation of a rare disease | Full Text | References | PDF (756.6 KB) | EPUB
  • 319 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Prospects and challenges for use of CAR T cell therapies in solid tumors
Sneha Ramakrishna, Valentin Barsan & Crystal Mackall
Pages: 503-516
Published online: 12 Mar 2020
AbstractforProspects and challenges for use of CAR T cell therapies in solid tumors | Full Text | References | PDF (1.3 MB) | EPUB
  • 1483 Views
  • 28 CrossRef citations
  • 0Altmetric
Review
Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review
Fabiola Atzeni, Valeria Nucera, James Galloway, Szekanecz Zoltán & Mike Nurmohamed
Pages: 517-524
Published online: 17 Dec 2019
AbstractforCardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review | Full Text | References | PDF (747.8 KB) | EPUB
  • 820 Views
  • 31 CrossRef citations
  • 0Altmetric
Review
Efficacy of biologics in atopic dermatitis
Jianni Wu & Emma Guttman-Yassky
Pages: 525-538
Published online: 03 Feb 2020
AbstractforEfficacy of biologics in atopic dermatitis | Full Text | References | PDF (1.2 MB) | EPUB
  • 2050 Views
  • 29 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Management of proctitis in ulcerative colitis and the place of biological therapies
Diletta De Deo et al.
Review Article | Published online: 17 Jun 2024
Open Access
An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
Zine-Eddine Khene et al.
Review Article | Published online: 13 Jun 2024
Progress in second-line antibody therapies for advanced esophageal squamous cell carcinoma
Nozomu Ogura et al.
Review Article | Published online: 11 Jun 2024
Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market
Isabel Río-Álvarez et al.
Review Article | Published online: 6 Jun 2024
View all latest articles